HighMark Wealth Management’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,800
Closed -$8.46K 601
2024
Q4
$8.46K Hold
2,800
﹤0.01% 313
2024
Q3
$7.08K Sell
2,800
-5,000
-64% -$17.8K ﹤0.01% 353
2024
Q2
$36.7K Sell
7,800
-186,011
-96% -$980K 0.02% 153
2024
Q1
$1.1M Buy
+193,811
New +$1.28M 0.68% 15

Other funds holding TELA

HighMark Wealth Management's TELA Position: Q1 2025 in Review

HighMark Wealth Management sold out of TELA Bio (TELA) in Q1 2025, closing a stake of 2,800 shares — an estimated $8.46K sold.

HighMark Wealth Management first reported a position in TELA in Q1 2024 and held it in 4 quarters. The position peaked at $1.1M in Q1 2024. 50 funds tracked by Wall St. Rank hold TELA as of Q1 2025.

  • HighMark Wealth Management reported no remaining TELA Bio position as of Q1 2025 after selling out during the quarter.
  • HighMark Wealth Management sold 2,800 TELA Bio shares in Q1 2025, an estimated $8.46K.
  • HighMark Wealth Management first reported a position in TELA Bio in Q1 2024 and held it in 4 quarters.
  • HighMark Wealth Management's TELA Bio position peaked at $1.1M in Q1 2024.
  • 50 funds tracked by Wall St. Rank held TELA Bio as of Q1 2025.

Based on HighMark Wealth Management's 13F filing for Q1 2025, filed 24 Apr 2025.